Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation

One of the major hallmarks of Parkinson disease is aggregation of the protein α-synuclein (αSN). Aggregate cytotoxicity has been linked to an oligomeric species formed at early stages in the aggregation process. Here we follow the fibrillation process of αSN in solution over time using small angle X-ray scattering and resolve four major coexisting species in the fibrillation process, namely monomer, dimer, fibril and an oligomer. By ab initio modeling to fit the data, we obtain a low-resolution structure of a symmetrical and slender αSN fibril in solution, consisting of a repeating unit with a maximal distance of 900 Å and a diameter of ∼180 Å. The same approach shows the oligomer to be shaped like a wreath, with a central channel and with dimensions corresponding to the width of the fibril. The structure, accumulation and decay of this oligomer is consistent with an on-pathway role for the oligomer in the fibrillation process. We propose an oligomer-driven αSN fibril formation mechanism, where the fibril is built from the oligomers. The wreath-shaped structure of the oligomer highlights its potential cytotoxicity by simple membrane permeabilization. This is confirmed by the ability of the purified oligomer to disrupt liposomes. Our results provide the first structural description in solution of a potentially cytotoxic oligomer, which accumulates during the fibrillation of αSN.

[1]  V. Subramaniam,et al.  Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core. , 2009, Biochimica et biophysica acta.

[2]  M. Fändrich,et al.  FTIR reveals structural differences between native β‐sheet proteins and amyloid fibrils , 2004, Protein science : a publication of the Protein Society.

[3]  D. Ehrnhoefer,et al.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.

[4]  Dmitri I. Svergun,et al.  Upgrade of the small-angle X-ray scattering beamline X33 at the European Molecular Biology Laboratory, Hamburg , 2007 .

[5]  V. Uversky,et al.  Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.

[6]  V. Uversky,et al.  Methionine oxidation, alpha-synuclein and Parkinson's disease. , 2005, Biochimica et biophysica acta.

[7]  Jean-Christophe Rochet,et al.  Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease. , 2004, Journal of molecular neuroscience : MN.

[8]  Dmitri I. Svergun,et al.  Uniqueness of ab initio shape determination in small-angle scattering , 2003 .

[9]  Hui Zhou,et al.  A new method for purification of recombinant human alpha-synuclein in Escherichia coli. , 2005, Protein expression and purification.

[10]  D I Svergun,et al.  Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. , 1999, Biophysical journal.

[11]  Dmitri I. Svergun,et al.  PRIMUS: a Windows PC-based system for small-angle scattering data analysis , 2003 .

[12]  Peter T. Lansbury,et al.  Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.

[13]  P. Lansbury,et al.  Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. , 2003, Biochemistry.

[14]  P. Lansbury,et al.  Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. , 2002, Biochemistry.

[15]  J. Hahn,et al.  Granular Assembly of α-Synuclein Leading to the Accelerated Amyloid Fibril Formation with Shear Stress , 2009, PloS one.

[16]  P. Lansbury,et al.  Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. , 2001, Biochemistry.

[17]  S. White,et al.  The Liquid-Crystallographic Structure of Fluid Lipid Bilayer Membranes , 1996 .

[18]  P. Lansbury,et al.  Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. , 2002, Journal of molecular biology.

[19]  Dmitri I. Svergun,et al.  Determination of the regularization parameter in indirect-transform methods using perceptual criteria , 1992 .

[20]  P. Lansbury,et al.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  V. Subramaniam,et al.  Membrane binding of oligomeric α‐synuclein depends on bilayer charge and packing , 2008, FEBS letters.

[22]  A. Fink The aggregation and fibrillation of alpha-synuclein. , 2006, Accounts of chemical research.

[23]  Armin Giese,et al.  Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding , 2007, The Journal of Neuroscience.

[24]  A. Fink The Aggregation and Fibrillation of α-Synuclein , 2006 .

[25]  E. Powers,et al.  The kinetics of nucleated polymerizations at high concentrations: amyloid fibril formation near and above the "supercritical concentration". , 2006, Biophysical journal.

[26]  Dmitri I Svergun,et al.  A Helical Structural Nucleus Is the Primary Elongating Unit of Insulin Amyloid Fibrils , 2007, PLoS biology.

[27]  Jesper Søndergaard Pedersen,et al.  A SAXS study of glucagon fibrillation. , 2009, Journal of molecular biology.

[28]  D. Otzen,et al.  Kinetic partitioning between aggregation and vesicle permeabilization by modified ADan. , 2009, Biochimica et biophysica acta.

[29]  V. Uversky,et al.  Methionine oxidation, a-synuclein and Parkinson's disease , 2005 .

[30]  R. Kayed,et al.  Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.

[31]  Shubo Han,et al.  The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils* , 2004, Journal of Biological Chemistry.

[32]  Armin Giese,et al.  Different species of alpha-synuclein oligomers induce calcium influx and seeding. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  D. Otzen,et al.  Strategies to increase the reproducibility of protein fibrillization in plate reader assays. , 2010, Analytical biochemistry.

[34]  V. Uversky,et al.  Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. , 2002, Biochemistry.

[35]  Jennifer C. Lee,et al.  α-Synuclein: Stable compact and extended monomeric structures and pH dependence of dimer formation , 2004, Journal of the American Society for Mass Spectrometry.

[36]  Min Zhu,et al.  The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils. , 2004, The Journal of biological chemistry.

[37]  L. Regan,et al.  A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. , 2003, Biophysical journal.

[38]  Dmitri I. Svergun,et al.  Electronic Reprint Applied Crystallography Dammif, a Program for Rapid Ab-initio Shape Determination in Small-angle Scattering Applied Crystallography Dammif, a Program for Rapid Ab-initio Shape Determination in Small-angle Scattering , 2022 .

[39]  D. Otzen,et al.  SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway. , 2010, Journal of molecular biology.

[40]  Maxim V. Petoukhov,et al.  ATSAS 2.1, a program package for small‐angle scattering data analysis , 2006 .